ArticleCureus2025
Fertility Prospects Among Testicular Cancer Survivors: Outcomes of Surgical Sperm Retrieval in Azoospermic Patients.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Since general improvements in the prognosis of cancer patients have been achieved through advances in surgery, radiotherapy, and chemotherapy, subsequent infertility in adolescents and young adults (AYAs) has become a serious problem. Sperm quality is often abnormal at the time of testicular cancer diagnosis. Anti-cancer therapy further impairs spermatogenesis and, following orchidectomy, leaves patients with a single testis, raising long-term concerns about fertility. We therefore evaluated fertility outcomes among testicular cancer survivors attending our male infertility clinic. Materials and methods From 2004 to 2023, 3,361 male infertility patients consulted our division, 117 (3.5%) of whom had a history of cancer treatment. Thirty-nine patients diagnosed with testicular cancer were evaluated for cancer treatment, semen findings, and infertility treatment. Seminoma was observed in 29 participants and non-seminomatous germ cell tumor (NSGCT) in 10 participants. Results Nineteen patients were followed up with a high orchidectomy alone. After orchidectomy, one patient received prophylactic radiotherapy to the retroperitoneal lymph node, and three were followed by chemotherapy (BEP (bleomycin, etoposide, and platinum); BLM, VP-19/CDDP). Fifteen patients underwent retroperitoneal lymph node dissection (RPLND) after BEP. One patient received high-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT), followed by RPLND, and then received additional BEP. Twenty-six patients had azoospermia, and 13 patients were oligoasthenozoospermic. Sperm retrieval surgery was attempted in 18 patients with azoospermia. Thirteen patients underwent microscopic testicular sperm extraction (micro-TESE), two received onco-TESE, two received microscopic epididymal sperm aspiration (MESA), and one received retrograde vasal sperm aspiration (ReVSA) due to reduced efficacy of medications for ejaculatory dysfunction (EJD) caused by RPLND. Motile sperm recovery was obtained through micro-TESE (5/13), onco-TESE (2/2), MESA (2/2), and ReVSA (1/1). Eleven healthy deliveries were observed following intracytoplasmic sperm injection (ICSI) using surgically retrieved sperm. Conclusions Testicular cancer survivors, even those with azoospermia, can achieve fatherhood through ICSI after precise evaluation and appropriate sperm retrieval surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.